PHYLLANTHUS PHYLLANTHUS NIRURI

PHYLLANTHUS (Phyllanthus niruri L.) +

P. amarus, P. debilis, P. fraternus and P. niruri are confused in the field and in the literature, and in this account too (true confession). The PH2 entries were under “black catnip” as P. amarus, with the warning “may be confused with Phyllanthus urinaria, P. niruri, P. debilis, and P. fraternus” (PH2). MPI data were applied to P. fraternus, KAB data to P. niruri L. HH3 recognized P. amarus and P. niruri among the similar species.

Activities (Phyllanthus) :
Aldose-Reductase-Inhibitor (1; 60P); Amebicide (1; ZUL); Analgesic (f; DAV); Antialcoholic (1; KEB); Antibacterial (1; HH2; TRA; WOI; ZUL); Anticancer (1; KAB); Antihepatomic (1; KEB); Antileukemic (1; KAB); Antipyretic (1; DAV; KAB; MPI; SKJ; TRA); Antiseptic (1; MPI; PH2; WOI); Antispasmodic (1; DAV; KAB; MPI; TRA); Antiviral (1; KEB; PH2; SKY; TRA); Aperitif (f; DAV); Astringent (f; KAB; SKJ); Bitter (1; KAB; MPI; PH2); Carminative (f; DAV); Deobstruent (f; SKJ); Depurative (f; JFM); Digestive (f; DAV); Diuretic (1; HHB; JFM; KAB; SKJ; WOI); DNA-Polymerase-Inhibitor (f; SKY); Emmenagogue (f; DAV); Fungicide (1; ZUL); Hepatoprotective (1; DAV; KAB; KEB; TRA); HIV-RT- Inhibitor (1; KEB); Hypoglycemic (1; DAV; KAB; KEB; MPI; TRA); Lactagogue (f; KAP; WOI); Laxative (f; DAV; KAB); Piscicide (1; WOI); Protein-Kinase-Inhibitor (1; HH2); Protisticide (1; ZUL); Sedative (f; 60P); Snakebite (f; HH2); Stomachic (f; SKJ); Tonic (f; DAV; KAB); Vermifuge (1; DAV; ZUL).

Indications (Phyllanthus) :
Acne (f; JFM); Alcoholism (1; KEB); Ameba (1; ZUL); Amenorrhea (f; 60P); Anorexia (f; DAV); Ascites (f; PH2); Bacteria (1; HH2; TRA; WOI; ZUL); Biliousness (f; JFM); Blackhead (f; JFM); Blennorrhagia (f; DAV); Calculus (f; JFM); Cancer (1; JLH; KAB; MPI); Cancer, abdomen (f; JLH); Cancer, colon (f; JLH); Colic (f; DAV; JFM; PH2; WOI); Conjunctivosis (f; HH3); Constipation (f; DAV; KAB; KAP; PH2); Cramp (1; DAV; KAB; MPI; PH2; TRA); Debility (f; HH3); Dermatosis (f; JFM; KAP); Diabetes (f; DAV; JFM; KAB; KEB; MPI; PH2); Diarrhea (f; PH2; WOI); Dropsy (f; DAV; MPI; SKJ); Dysentery (f; DAV; MPI; PH2; SKJ); Dyspepsia (f; MPI; WOI); Dysuria (f; JFM; KAP); Edema (f; JFM; KAP; MPI; SKJ); Enterosis (f; JFM; JLH); Escherichia (1; HH3); Fever (1; DAV; HHB; KAB; MPI; PH2; SKJ; TRA); Flu (f; DAV); Fungus (1; MPI; ZUL); Gallstone (f; HH3); Gastrosis (f; HHB; JFM; PH2); Gonorrhea (f; HH3; MPI; SKJ); Gout (f; JFM); Gravel (f; JFM; 60P); Hepatosis (2; KEB; MPI; SKY); Herpes (1; HH3); High Cholesterol (1; 60P); HIV (1; ABS); Hyperglycemia (1; DAV; KAB; KEB; MPI; TRA); Hyperuricemia (f; JFM); Infection (1; MPI; PH2; ZUL); Infertility (f; PH2); Insomnia (f; 60P); Itch (f; DAV; KAP); Jaundice (2; DEP; HHB; HH3; KEB; MPI; SKY); Leukemia (1; KAB; MPI); Malaria (f; DAV; DEP; KAB; HH3; PH2); Menorrhagia (f; KAP; MPI); Mycosis (1; MPI; ZUL); Nephrosis (f; DAV; JFM); Nervousness (f; 60P); Ophthalmia (f; KAP; MPI; PH2; WOI); Ovary (f; JFM); Pain (f; DAV); Parasite (1; ZUL); Prostatosis (f; DAV); Prolapse (f; JFM); Pulmonosis (f; 60P); Ringworm (1; ZUL); Scabies (1; DEP; KAB; PH2; ZUL); Snakebite (f; HH3); Sore (f; DEP; MPI; PH2; WOI); Staphylococcus (1; HH3; 60P); Stomachache (f; DAV); Stone (f; HH3); Swelling (f; KAB; MPI; SKJ); Tachycardia (f; PH2); Tenesmus (f; DAV); Tumor (f; JLH); Ulcer (f; JFM; SKJ; 60P); Urogenitosis (f; DEP; KAB; MPI; PH2); UTI (f; SKJ); Vaginosis (f; DAV); VD (f; KAB; HH3); Virus (1; HH3; KAB; KEB; PH2; SKY; TRA); Womb (f; JFM); Worm (1; DAV; ZUL); Wound (f; PH2).

Dosages (Phyllanthus) :
900–2700 mg plant powder/day/3 months (SKY); 10 plants/liter water (PH2); 3–6 g powdered herb (KAP); 14–28 ml tea (KAP); 2–6 ml extract (1:2) (KEB).

Contraindications, Interactions, and Side Effects (Phyllanthus) :
Not covered (AHP; KOM; PNC). “Hazards and/or side effects not known for proper therapeutic dosages” (PH2). None reported (SKY).

Extracts (Phyllanthus) :
Alcoholic extracts bactericidal to Escherichia coli and Micrococcus pyogenes (WOI). Lignans are hepatoprotective in vitro (KEB). Aqueous extracts (with repandusinic acid A) inhibit HIV-RT in vitro. Aqueous extracts are comparable to tolbutamide as oral hypoglycemic (ZUL). LD50 dry aqueous whole plant extract 3300 mg/kg ipr mouse (HH3).